However, the situation is ideally established based on the foundation that blood insulin concentration derives exclusively from absorption of the subcutaneously injected insulin and no endogenous insulin contributes to the observed GIR, e.g., a condition in patients with T1DM (Kerner et al., 1991; Porcellati et al., 2015). This evidence concerns the gene INS and type 1 diabetes mellitus.